Biogen Inc. (BVMF:BIIB34)
Brazil · Delayed Price · Currency is BRL 139.01
-0.43 (-0.31%)
At close: Nov 11, 2025
Biogen Market Cap
Biogen has a market cap or net worth of 125.45 billion as of November 13, 2025. Its market cap has decreased by -18.48% in one year.
Market Cap
125.45B
Enterprise Value
139.38B
Revenue
53.65B
Ranking
n/a
PE Ratio
14.63
Stock Price
139.01
Market Cap Chart
Since September 17, 1991, Biogen's market cap has increased from 149.34M to 125.45B, an increase of 83,906.48%. That is a compound annual growth rate of 21.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2025 | 125.45B | -8.97% |
| Dec 31, 2024 | 137.82B | -24.25% |
| Dec 29, 2023 | 181.94B | -13.70% |
| Dec 30, 2022 | 210.81B | 7.36% |
| Dec 31, 2021 | 196.36B | 0.35% |
| Dec 31, 2020 | 195.68B | -9.08% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 101.14B |
| Raia Drogasil | 39.23B |
| Hypera | 16.31B |
| Fleury | 8.62B |
| Odontoprev | 6.72B |
| Empreendimentos Pague Menos | 2.94B |
| Diagnósticos da América | 2.56B |
| Blau Farmacêutica | 2.26B |